Kanagawa, Japan

Miyuki Yoshida



Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Kamakura, JP (2011)
  • Kanagawa, JP (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Miyuki Yoshida

Introduction

Miyuki Yoshida is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment.

Latest Patents

Yoshida's latest patents include a compound known as a 1-(2H)-isoquinolone derivative. This invention provides a compound represented by a specific formula, which includes various substituents that enhance its pharmaceutical properties. Additionally, she has developed pyrimidine derivatives that serve as PI3K inhibitors, offering promising results as preventive or therapeutic agents for cancer due to their superior stability and water-solubility.

Career Highlights

Miyuki Yoshida is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at this institution has allowed her to focus on innovative drug development, contributing to advancements in medical science.

Collaborations

Throughout her career, Yoshida has collaborated with notable colleagues, including Kazuo Hattori and Satoshi Niizuma. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Miyuki Yoshida's contributions to the field of pharmaceuticals exemplify the importance of innovation in medical research. Her patents reflect a commitment to developing effective treatments for serious health conditions, particularly cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…